|
Volumn 11, Issue 3, 2001, Pages 203-209
|
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention
a a a a a a a a a a |
Author keywords
Complications; Coronary intervention; GP IIb IIIa antagonists
|
Indexed keywords
ABCIXIMAB;
CREATINE KINASE MB;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
TIROFIBAN;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BLEEDING;
COMPARATIVE STUDY;
CONTROLLED STUDY;
COST CONTROL;
DATA ANALYSIS;
DEATH;
DRUG COST;
DRUG MECHANISM;
DRUG USE;
ENZYME BLOOD LEVEL;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART CATHETERIZATION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REVASCULARIZATION;
HOSPITALIZATION;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RETROSPECTIVE STUDY;
SHORT COURSE THERAPY;
THROMBOCYTE AGGREGATION INHIBITION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
CREATINE KINASE;
DRUG THERAPY, COMBINATION;
FEMALE;
FIBRINOLYTIC AGENTS;
HEMORRHAGE;
HEPARIN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROSPECTIVE STUDIES;
RECURRENCE;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
TYROSINE;
|
EID: 0035161889
PISSN: 09295305
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011904718960 Document Type: Article |
Times cited : (4)
|
References (17)
|